ETF盘中资讯|脑机接口、AI医疗引爆，港股通医疗主题指数开年7连涨！T+0投资利器来袭，159137上市交易，实时成交逾亿元

Core Viewpoint - The Hong Kong stock market's healthcare sector is experiencing significant activity, particularly in brain-computer interfaces and AI healthcare, with notable gains in various stocks and the launch of a new healthcare ETF [1][3]. Group 1: Market Performance - The Hong Kong Stock Connect healthcare sector index has risen for seven consecutive days since the beginning of 2026, with a peak increase of over 1% on January 12 [1]. - Notable stock performances include: - Yimray Sunshine: +8.76% with a market cap of 3.3 billion - Aidi Kang Holdings: +6.81% with a market cap of 3.7 billion - MicroPort Scientific: +6.49% with a market cap of 27.7 billion - Alibaba Health: +2.77% with a market cap of 959 billion [1]. Group 2: ETF Launch and Characteristics - The newly launched Hong Kong Stock Connect Healthcare ETF (159137) aims to track the healthcare innovation index, covering key sectors such as CXO, AI healthcare, medical devices, and innovative drugs [3]. - The healthcare theme index has shown high elasticity and volatility, with a maximum increase of over 148% during the last healthcare bull market, significantly outperforming comparable indices [3][4]. Group 3: Recent Developments and Innovations - Recent advancements in brain-computer interfaces and AI healthcare have led to increased attention in the healthcare sector, with OpenAI launching ChatGPTHealth and Neuralink planning large-scale production of brain-computer interface devices by 2026 [4][5]. - Tsinghua University announced the development of an AI-driven high-throughput drug virtual screening platform, highlighting the growing intersection of AI and healthcare [5]. - The National Medical Products Administration in China is working on standards for medical devices using brain-computer interface technology, indicating a supportive regulatory environment [5]. Group 4: Investment Opportunities - The A-share market offers investment tools such as the largest healthcare ETF (512170), which includes 12 AI healthcare and brain-computer interface concept stocks, with a combined weight of over 36% [6]. - The current price-to-earnings ratio of the CSI Healthcare Index is 35.46, indicating a favorable valuation compared to historical averages [6].